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Summary Natural killing (NK) by lymphocytes from normal individuals against primary and established
ovarian carcinoma cell lines was tested in short-term chromium release assays. Two established cell lines and
5/6 primary cell lines tested showed significant susceptibility to NK. Primary cell lines are, in general, less
sensitive to NK than long-term cultured target cells. A common NK recognition determinant on ovarian
carcinoma cells and on the erythroleukaemic K562 cells was demonstrated by cold target inhibition assays.
The recognition structure was also present on an ovarian cell line resistant to NK but not on the insensitive
leukaemic cell line, SB. The activity against ovarian carcinoma cells was associated with the presence of large
granular lymphocytes (LGL) previously shown to be the major effector cells against K562 targets. In fractions
obtained by Percoll gradient centrifugation of lymphocytes, only fractions with a high content of LGL
demonstrated good NK activity. LGL mediated NK against both non-adherent K562 and the adherent
ovarian carcinoma target cells independent of monocytes
Natural killing (NK) is a spontaneous cytolytic
activity of lymphocytes from unsensitized
individuals. Natural killer cells demonstrate a wide
range of reactivity against many cultured cells and
certain normal tissues (Herberman et al., 1979). For
human NK, the erythroleukaemic cell line, K562, is
widely used as the standard target. Cells mediating
NK have been partially enriched by centrifugation
on Percoll gradients and are characterized as low
density, large granular lymphocytes (LGL)
(Timonen et al., 1981; Timonen & Saksela, 1981).
LGL are non-adherent and non-phagocytic, bear
low affinity receptors for sheep erythrocytes, are Fc
receptor positive for IgG and express no surface Ig
(Herberman et al., 1979; Timonen et al., 1981). NK
activity can be enhanced by interferon (IFN), and
the enhanced activity has also been shown to be
mediated by LGL (Timonen et al., 1981; de
Landazuri et al., 1981).
While LGL have been shown to be solely
responsible for NK against non-adherent leukaemic
target cells, contradictory results have been reported
as to whether monocytes are involved in NK
against adherent targets. In the study by de Vries et
al., (1980) NK against adherent target cells was
detected only in mixtures of lymphocytes and
monocytes, and neither cell population alone had
appreciable activity against adherent targets. In
contrast, de Landazuri et al. (1981) have shown that
NK against non-adherent as well as adherent target
cells was mediated by LGL alone and that
monocytes had no effect on either activity.
NK has evoked considerable interest because of
its possible role in natural immune surveillance of
tumours (Herberman et al., 1979). If NK is
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important in the defence against tumours, it should
be possible to show that freshly-isolated tumour
cells are sensitive to NK or express the relevant NK
recognition determinant(s). However, difficulties in
separating tumour cells from non-malignant cells
have limited studies of this kind. For example,
mechanical and enzymatic treatments have been
utilized by different research laboratories to
separate tumour cells, but this may lead to variable
damage to the tumour cells (Pretlow & Pretlow,
1980). Cells present in ascites fluids are already in
suspension, and therefore provide a convenient
source of tumour cells requiring no further
dispersement.
In this study, we have used 2 long-term ovarian
carcinoma cell lines and 6 primary ovarian
carcinoma lines obtained from ascites fluids to test
their sensitivity to NK. NK activity against ovarian
tumour cells has been compared with that against
K562 with respect to characteristics of the effector
cells and the expression of NK recognition
determinants on target cells.
Materials and methods
Tumour cells
Long-term ovarian carcinoma cell lines 2008 and
2774 were obtained from Dr. P. DiSaia (University
of California, Irvine) and maintained in Ham's FIO
medium (FIO) supplemented with 20% (v/v) heat
inactivated foetal bovine serum (FBS), 150 units
ml-' of penicillin, 150pgml-1 of streptomycin
(Flow Laboratories, McLean, VA) and 4mM L-
glutamine (Grand Island Biological Co., Grand
Island, NY) (20%-FIO). Subcultures were prepared
by treating confluent cultures with 0.25% (w/v)
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trypsin and ethylenediamine-tetraacetic acid,
disodium salt, (0.2pg -1) in Dulbecco's PBS.
Human leukaemic cell lines, K562 and SB, were
maintained as stationary suspension cultures in
RPMI 1640 medium (Flow) with 10% FBS and the
same concentrations of antibiotics and L-glutamine
as in 20%-FIO. Cells were passaged every other day.
All cultured cells were fed with respective culture
medium 3 times a week and always on day before
use.
Preparation ofcells from ascites fluids
Ascites fluids were obtained from patients at Duke
University Hospital who had been diagnosed as
having ovarian carcinoma. The ascites fluids were
centrifuged at 400g for 10min and the cell pellets
were treated by hypotonic shock to lyse red cells.
The recovered cells (adjusted to 107ml -1) were
cultured in 20%-F1O in plastic tissue culture flasks
(75cm2) (Corning Glass Works, Corning, NY)
overnight at 37°C with humidified 5% CO2 in air.
The non-adherent cells were rinsed off with fresh
FIO. The adherent cells were fed with 20%-FIO.
Primary cell lines except those mentioned below
were used within one week after the cells were
recovered from ascites fluids, and were fed with
medium one day before use. Ascites cell
preparations Cx551, Cx612, Cx671 and Cx673,
following recovery of the cells from the ascites, were
treated with hypotonic shock, and the recovered
cells were cryopreserved at -70°C in FIO with 30%
FBS and 10% (v/v) dimethyl sulfoxide. They were
later recovered from storage and cultured like the
other primary cell lines. The extent of macrophage
contamination in the tumour cell preparations was
determined by peroxidase staining and
morphologically by Giesma staining (see below).
Greater than 90% of the cells in primary cultures
were epithelial tumour cells.
Preparation ofperipheral blood lymphocytes (PBL)
Human peripheral blood mononuclear cells were
isolated from defibrinated or heparinized blood as
previously described (Shau & Dawson, 1982).
Adherent cells were depleted by incubating the
mononuclear preparations (4 x 106 cellsml-1) at 370
for 1 h on plastic tissue culture flasks and by
passing cell suspensions through nylon wool
columns. The harvested PBL were resuspended in
control medium (CM), containing FIO with 10°/
FBS, antibiotics and L-glutamine.
Percollfractionation ofPBL
NK effector cells were enriched by centrifugation on
discontinuous density gradients of Percoll (Timonen
et al., 1981; Timonen & Saksela, 1981). Five
different concentrations of Percoll in medium were
prepared by mixing Percoll (Pharmacia Chemicals,
Uppsala, Sweden) with F10 containing 15mM
HEPES. The final concentrations of Percoll (v/v)
were 54, 49.1, 45, 41.5 and 38.6%, respectively.
Refractive indices of these fractions ranged from
1.342-1.345. Five ml of each Percoll fraction was
carefully layered into a graduated 50ml centrifuge
tube (Vanguard International, Meptune, NJ). Three
ml of CM containing 100-200 x 106 non-adherent
PBL was added to the top of the gradient. Two ml
of CM was layered on top of the cells to prevent
formation of a meniscus at the surface of the cell
layer. The gradient was centrifuged at 100g for
50min with slow acceleration and deceleration.
Cells were collected with Pasteur pipettes between
the different Percoll concentrations and designated
as fractions (fr) 1/2, 2/3, 3/4 and 4/5. Cells at the
bottom of centrifuge tubes were designated fr5.
Those harvested cells were washed once and
resuspended in CM at desired cell concentrations.
Cell morphology and histochemistry
Morphological characterization of cells was by
differential histochemical staining of cytocentrifuged
preparations. Cells in CM were centrifuged at
500rpm for 5min onto microscope slides, using a
Cytospin centrifuge (Shandon Southern Instruments
Inc., Bewickley, PA). The slides were allowed to air-
dry before fixing and staining.
Giemsa staining of LGL was performed
according to procedures described by Timonen et
al. (1981). They were identified as large lymphocytes
with kidney-shaped nuclei, a weakly basophilic
cytoplasm with azurophilic granules, and a
relatively high cytoplasmic nuclear ration.
Myeloperoxidase staining was performed
according to the procedure of Kaplow (1965) with
Safranin 0 counterstain. Cells with positive
myeloperoxidase activity were identified by discrete
blue granules in the cytoplasm.
Natural killing assay
Adherent target cells (TC) grown in monolayers
were harvested with rubber policemen and were
pipetted through Pasteur pipettes several times to
disperse cell clumps. Cells grown in suspension
cultures were used without this treatment. TC were
radiolabelled with [51Cr] sodium chromate and
NK assays were performed in round bottom
microwells as previously described (Shau &
Dawson, 1982).
Cytolysis of TC was defined as the percentNK AGAINST OVARIAN CARCINOMA 689
specific 51Cr released or {(experimental release-
spontaneous release) (maximum release-
spontaneous release)} x 100%. Experimental release
was determined from the amount of 51Cr released
by TC when incubated with effector cells and
measured as cpm. Spontaneous release was
determined from the amount of 5"Cr released by
TC when incubated in CM alone. Maximum release
was determined from the amount of 51Cr released
by TC when incubated with 5% (v/v) Triton X-100
detergent. Each assay was done in triplicate, and
the data were processed by a PDP-11/34 computer
(Digital Equipment Corp., Maynard, MA). The
results are presented as % 5"Cr released +s.d.
Competitive inhibition with unlabelled TC
For cold target inhibition, different doses of
unlabelled TC were added together with fixed
concentrations of EC and 51Cr-labelled TC to
microtiter wells to compete for TC-EC interaction
during NK assays. Percent inhibition was defined as
(1-A/B) x 100%; A being the % 51Cr release in
assays with cold inhibitors, and B, the % 5"Cr
release in assays without inhibitor. Unlabelled TC
were considered competitive to labelled TC only
when there was a dose-response relationship
between % inhibition and number of unlabelled TC
added. Cytolysis of TC by EC in the absence of
unlabelled inhibitors was assigned 0% inhibition.
Interferon
Human IFN-oa (Hu IFN-ax) was prepared as
previously reported (Shau & Dawson, 1981). The
antiviral acticity was measured by inhibition of the
cytopathic effect of vesicular stomatitis virus in
Vero cells (Armstrong, 1971). The IFN preparation
was confirmed to be oc type by neutralization of the
antiviral activity with anti-Hu IFN-ci serum
obtained from the NIH (G-026-502-568), and by its
resistance to pH 2 treatment. A Hu IFN-a
preparation, obtained from the NIH (G-023-901-
527), was used as standard in the assays. A
concentration of 30-120 units/well was used in NK
assays.
Results
NK activity against ovarian tumour cells
Susceptibility of ovarian tumour cells to NK
activity was first tested with the established cell
lines 2008 and 2774. Figure 1 shows the results of
typical experiments using 2008 and 2774 as TC in
NK assays. The amount of 51Cr released from both
TC showed a clear dose-response relationship with
the concentration of EC used. The extent of TC
cytolysis by EC also increased with time of
incubation. The data therefore indicate that both
established cell lines derived from ovarian tumours
are sensitive to NK.
In vitro culturing of some tumour cells has been
known to alter their susceptibility to NK (Vanky et
al., 1980; de Vries et al., 1975). In addition, both cell
lines 2008 and 2774 are infected with mycoplasma,
which may also increase tumour cell sensitivity to
NK (Birke et al., 1981). Cell line 2774 has recently
been cured of mycoplasma contamination and
showed similar sensitivity to NK as the original
mycoplasma-infected cell line (Howard et al.,
unpublished data). Therefore, we compared the
results of the initial study with NK activity against
primary ovarian tumour cell lines to evaluate the
culturing artifact. NK activity against cell lines 2774
and 6 different primary ovarian tumour cell lines
were tested in 4 experiments (Table I). Five of the 6
primary tumour cell lines showed significant
susceptibility to NK and a dose-dependent cytolysis
with increasing EC/TC ratio. Among the susceptible
primary cell lines the sensitivity to NK varied, with
only one (Cx608) showing greater susceptibility to
NK than 2774. Like NK activity against K562, the
activity against ovarian carcinoma cell lines 2774
and Cx608 was enhanced by the addition of
exogenous IFN (Table I). However, IFN failed to
induce any activity against the resistant Cx680.
Comparison ofNK against 2774 and K562
To determine whether NK activity against ovarian
tumour cells and K562 targets was mediated by the
same population of effector cells, competitive
inhibition assays with the 2 types of target cells
were performed. The cross-inhibition between 2008
and 2774 cell lines (Figure 2) suggested the presence
of common determinants recognized by EC in these
two cell lines. Inhibition by K562 and the failure of
NK insensitive SB cells to inhibit the cytolysis of
2008 and 2774 were also indicative of a common
determinant on sensitive cells.
However, in experiments where primary tumour
cell lines were used, the difference between sensitive
and resistant targets was less distinct. Table II
shows that for the primary tumour cell lines tested,
only one (Cx680) showed significant inhibition of
NK against labelled K562, and 3 (Cx551), Cx671
and Cx680) were inhibitory of NK against 2774.
Among the effective inhibitors against 2774, one
(Cx680) was totally resistant to NK, and two
(Cx551 and Cx67l) had moderate sensitivity to NK
(Table I). Cell lines Cx612 and SB were not
effective inhibitors against either K562 or cell line690 H. SHAU et al.
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Figure 1 NK activity of normal PBL against ovarian carcinoma cell lines (a) 2008 and (b) 2774. Length of
assays: (e), 2h; (0), 4h; (A), 6h; (A), 8h.
2774; this is consistent with their resistance to direct
NK cytolysis (Table I). Therefore, the existence of a
common recognition determinant generally
correlates with target cell susceptibility to NK,
while Cx680 is an interesting exception.
Percoll gradientfractionation ofeffector cells
Percoll gradients were used in this study to obtain
LGL, whose NK activity against K562 and 2774
was tested. Table III depicts results of a typical
experiment. NK activity against 2774 and K562 had
very similar profiles in EC fractionated on Percoll
gradients. Cells with low density recovered from
fr2/3 showed the highest activity. The recovery of
cells from frl/2 was always very low. Repeated tests
at low EC/TC ratios showed that NK activity
against both K562 and 2774 was usually lower in
frl/2 than the input fraction and was always lower
than fr2/3. Cells from fr3/4 and fr4/5 usually have
comparable or lower NK activity than input cells.
Only marginal NK activity could be detected in fr5.
The morphology of EC from each fraction in the
Percoll gradient was studied by different
histochemical stains. Consistent with previous
reports, LGL represent a small proportion of
lymphocytes, and NK activity against both K562
and 2774 was highest in fractions with the highest
proportion of LGL. Cells with myeloperoxidase
activity always accounted for < 1% in all the
fractions. As shown in Figure 3, using Percoll
fractionated effectors, the enhancement of NK by
IFN was also greatest in the originally active LGL-
enriched fraction.
Discussion
In our study with 2 long-term ovarian carcinoma
cell lines and 6 primary cell lines obtained from the
ascites of patients with ovarian carcinoma, all but
two showed significant susceptibility and a dose-
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% specific chromium releasec (mean +s.d.)
Exp.
no. Tca IFb EC/TCd= 100 50 25 12.5 6.25
1 CX551 15.2+3.3 4.7+2.6 2.6+2.9 nte nt
CX602 8.4+0.9 7.1+0.9 4.2+0.7 1.7+0.5 nt
2774 - 27.3+2.8 17.1+1.8 9.6+1.0 4.6+0.6 nt
2 CX612 nt 4.7+0.6 2.3+0.9 1.5+0.5 -0.6+ 1.9
3 CX608 nt 23.4+2.3 13.7+0.5 7.1 +0.6 7.5+ 1.2
+ nt 28.1+1.7 19.4+1.5 13.8+1.7 nt
2774 - nt 14.3+0.8 9.0+1.4 4.6+0.6 2.5+0.5
+ nt 31.4+3.8 24.9+2.2 18.1+ 1.6 13.3+ 1.1
EC/TC= 80 40 20 10 5
4 CX671 - 28.0+ 1.8 29.6+4.2 21.7+ 1.3 13.3+2.6 nt
2774 - 53.3+ 1.3 48.9+0.9 39.3+8.8 23.1 + 1.2 nt
5 CX680 - nt 1.1 + 1.9 3.4+2.3 4.5+ 1.9 8.9+4.0
+ nt 2.0+3.2-1.4+2.5 3.8+2.0 1.7+3.2
2774 - nt 18.2+ 1.7 9.8+ 1.0 4.8+0.6 3.6+0.7
+ nt 24.6+ 1.5 14.7+ 1.1 9.1 + 1.1 4.9+0.6
aOvarian tumour cell line 2774 and various primary tissue lines (C.) were used as
target cells.
bExogenous Hu IFN-a (160u.mI 1) added to the assay (+).
cLength of assay =6h.
dEffector cell/target cell ratio.
eNot tested.
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Figure 2 Competitive inhibition in NK assays against labelled (a) 2008 and (b) 2774 with unlabelled
inhibitors: (A), 2008; (0), 2774; (6), K562; (U), SB. EC/TC = 50. Length of assay =6h.
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Table II Cold target inhibition by K562 and ovarian carcinoma cells in NK
assays against radiolabelled K562 and 2774 cells
% inhibition ofNKb
K562 target cells' 2774 target cellsd
Exp.
No. ICa IC/TC= 8 4 2 1 8 4 2 1
1 K562 78 67 52 36 83 84 62 47
2774 46 20 14 11 73 56 52 39
CX551 17 13 4 3 65 45 39 28
CX612 9 10 1 2 13 -2 0 6
SB 7 4 -3 -6 nte nt nt nt
2 K562 87 72 55 39 92 83 47 18
2774 27 31 21 10 88 90 71 17
CX671 10 9 6 7 36 21 14 -5
CX673 10 9 7 2 6 1 4 -5
SB 7 6 3 nt 17 2 4 -6
3 K562 74 48 39 18 90 79 47 34
2774 36 18 21 2 82 82 62 51
Cx680 50 42 36 24 89 86 78 67
aUnlabelled tumour cells added to NK assays as inhibitor cells (IC).
b% inhibition of radiolabelled target cell (TC) lysis by unlabelled inhibitor cells.
CEffector cell/target cell ratio = 10; length of assay, 3h.
dEffector cell/target cell ratio =40; length of assay, 6h.
eNot tested.
Table III Morphology and NK activity of Percoll gradient
fractionated effector cells
% specific 51Cr release
(mean+s.d.)
Cell %
fraction cells % K562 2774
(fr) recovered LGL' Target cellsb Target cellsc
Inputd 4 15.8+1.1 1.7+0.5
1/2 4 15 12.7+1.1 nte
2/3 10 77 54.9+2.1 10.6+0.5
3/4 52 11 23.1+1.2 0.9+0.6
4/5 26 15 19.8+1.4 1.1+0.6
5 8 3 7.3+1.6 -1.4+0.5
aDetermined by Giesma staining.
bEC/TC =5, 2-h assay.
CEC/TC=20, 4-h assay.
dInput cells were mononuclear cells, depleted of monocytes by
plastic adherence and nylon wool columns before fractionation.
Peroxidase-positive cells <1 % in input population and all
fractions.
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Figure 3 Enhancement of NK against 2774 in Percoll
fractionated effector cells by IFN-a. EC/TC=5. Six-
hour assay. (0), with IFN; (0), without IFN.
dependent cytolysis with increasing number of EC
in NK assays. However, the degree of susceptibility
varied among the TC, with most primary cell lines
less sensitive to NK than long-term cell lines.
Results from other studies have shown that fresh
tumour cells are, in general, quite resistant to NK
(Vose & Moore, 1980; Mantovani et al., 1980). This
is not necessarily a contraindication of the
surveillance role proposed for NK, because
resistance itself can be argued as a reason why
tumours develop despite near normal NK activity
in the peripheral blood of some cancer patients
(Mantovani et al., 1980; Kadish et al., 1981).
Resistance may be due either to lack of the
appropriate NK recognition structure (or
determinant) or properties inherent in the tumour
cell membrane.
Competitive inhibition has been used to test for
the presence of NK recognition determinants on
TC. In most reports with long-term cultured cells,
although heterogeneity exists, there is a good
agreement between sensitive TC and effective
inhibitors (Koren & Williams, 1978; Callewaert et
al.). Roder and colleagues reported the isolation of
a recognition structure from the murine YAC-1 cell
line which has been shown to be expressed only by
sensitive TC (Roder et al., 1979). In our experiments
with K562, 2008 and 2774, the cross inhibition
among these TC indicates the presence of a
common determinant. The inability of the
insensitive SB target to compete with labelled,
sensitive TC also agrees with this hypothesis
(Callewaert et al., 1979; Koren & Williams, 1978).
In experiments with primary tumour cell lines,
two (Cx551) and Cx671) were significantly
inhibitory to the cytolysis of 2774 but were
ineffective in competition with K562 (Table II).
Thus, there seems to be a quantitative difference in
the common recognition determinant present on
K562 and on 2774. As K562 is more sensitive to
NK than 2774, which in turn shows greater
sensitivity to NK than Cx551 and Cx671, it is
possible that the number of NK recognition sites
per cell also follows this order. As a result, at the
inhibitor/target ratios we tested, although enough
determinant sites were presented by the unlabelled
Cx551 and by unlabelled Cx671 to compete with
2774, much less inhibition was observed in
competition with labelled K562. No significant
recognition sites could be detected on Cx612 or
Cx673, as neither was inhibitory of NK against
K562 or 2774 (Table II). This is consistent with our
observation that Cx612 showed little susceptibility
to NK. However, Cx680, which was totally
insensitive to direct NK was a very effective
inhibitor, comparable to the sensitive cell line 2774.
Similar results have been reported by Vose &
Moore (1980). In their study, most fresh lung
tumour cells were resistant to NK and were
ineffective inhibitors in competitive inhibition assays
using K562 as labelled TC. However, in 2/14 cell
preparations they tested, significant inhibition
against K562 was observed for resistant tumour
cells. Inhibition of K562 cytolysis by fresh breast
and lung tumour cells has also been reported by
Ortaldo et al. (1977). Mantovani et al. (1980) also
observed that NK-resistant, fresh ovarian tumour
cells were inhibitory to NK against K562. Our
results suggest that NK recognition determinant(s)
may be expressed by some resistant tumour cells.
Nonetheless, for the majority of the primary tumour
cell lines tested, sensitive TC were generally better
inhibitors. We have also shown that the presence of
NK recognition determinant(s), although sometimes
not detected by competitive inhibition assays using
K562 as labelled TC, can be detected using the
NK-sensitive 2774 cells as labelled TC.
Recent reports have clearly demonstrated that
human NK as measured against K562 is mediated
by LGL (Timonen et al., 1981; Timonen & Saksela,
1981). As for the nature of EC in NK against other694 H. SHAU et al.
targets, contradictory results have been reported.
De Vries et al. (1980) separated peripheral blood
mononuclear cells according to their cell sizes by
velocity sedimentation at unit gravity and tested
NK activity in each fraction. The large cell fraction
which contained mostly monocytes had little
activity against any targets they tested. Although
the fraction with small cells, mainly lymphocytes,
was cytolytic for 2 leukaemic target cell lines, K562
and MOLT-4, very little activity against adherent
target cell lines was observed. High activity against
adherent cell lines was detected only in mixtures of
both lymphocytes and monocytes. In contrast, de
Landazuri et al. (1981) used Percoll gradients to
fractionate PBL which had been depleted of
monocytes by plastic adherence and nylon wool
column, and found that the LGL-enriched fraction
contained most of the NK activity against adherent
as well as leukaemic targets. Addition of monocytes
to the LGL-enriched EC did not cause any change
in the NK activity. Neither did monocytes induce
any NK activity in a high density lymphocyte
fraction which consisted primarily of small
lymphocytes. Furthermore, in the study by Uchida
et al. (1982), peripheral blood monocytes obtained
from patients after surgery were shown to suppress
NK.
The results of our study are in accordance with
those of de Landazuri et al. (1981). We found high
NK activity only in EC populations with a high
percentage of LGL, and the monocytes were not
required for activity against either K562 targets or
ovarian cell line 2774 and the other primary
adherent line.
Enhancement of NK activity against 2774 by Hu
IFN-a was observed primarily in fr2/3 of the
Percoll gradients where the LGL content and
original NK activity were highest. This is also
consistent with recent reports that IFN-enhanced
NK activity against both leukaemic targets and
adherent targets was confined to LGL-enriched
fractions (Timonen et al., 1981; de Landazuri et al.,
1981). However, an interesting observation has been
made by Vanky et al. (1980) that IFN only
increases the NK activity against various allogeneic
tumour cells but not against autologous tumour
cells. Whether this is the case with ovarian tumour
cells remains to be determined.
The results of our study suggest that natural
cytotoxicity against adherent ovarian tumour cell
lines is mediated by effector cells currently
indistinguishable from those effective against
standard NK targets though heterogeneity of
effector cells in the LGL fraction can not be
excluded. Further, the variable susceptibility of
primary tumour cell lines to NK, is associated with
the expression of NK recognition structure(s) on
those cells and support the notion that NK cells
may have a role in surveillance to tumour
(Herberman et al., 1979).
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